INGN INOGEN INC Management Changes 8-K Filing 2024 - Departure of Directors or Certain Officers Inogen Inc announces the departure of Dr. Stanislav Glezer, Executive Vice President, R&D and Chief Medical Officer, and the execution of a separation agreement and release related to his termination.Get access to all SEC 8-K filings of the INOGEN INC